Table 1 Clinical features of subjects.

From: Metabolomics-Based Discovery of Molecular Signatures for Triple Negative Breast Cancer in Asian Female Population

Subjects

TNBC

CN

Sample size

31

31

Age (years), mean (SD)

51.5 (10.2)

51.7 (10.6)

Menopause status, n

Premenopausal

9

10

Perimenopausal

13

12

Postmenopausal

9

9

Cancer stage, n

I

4

NA

II

17

NA

III

10

NA

Cancer type, n (%)

(ER−, PR−, HER2−), n (%)

100%

NA

Sample collection before or after medication

before

NA

Sample collection before or after surgery

before

NA

  1. The table shows age and range of subjects at the time of blood sample collection.
  2. NA: not applicable.
  3. TNBC, Triple negative breast cancer; CN, healthy controls; ER−, negative expression of estrogen receptor; PR−, negative expression of progesterone receptor; HER2−, negative expression of human epidermal growth factor receptor.
Back to article page